Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02225730 · ClinicalTrials.gov registry record
Imaging Collaterals in Acute Stroke (iCAS)
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 187
- Enrollment target
NCT02225730: Completed study, sponsored by Stanford University.
NCT02225730 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 187 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02225730 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
Study Summary
Stroke is caused by a sudden blockage of a blood vessel that delivers blood to the brain. Unblocking the blood vessel with a blood clot removal device restores blood flow and if done quickly may prevent the disability that can be caused by a stroke. However, not all stroke patients benefit from having their blood vessel unblocked. The aim of this study is to determine if special brain imaging, called MRI, can be used to identify which stroke patients are most likely to benefit from attempts to unblock their blood vessel with a special blood clot removal device. In particular, we will assess in this trial whether a noncontrast MR imaging sequence, arterial spin labeling (ASL), can demonstrate the presence of collateral blood flow (compared with a gold standard of the angiogram) and whether it is useful to predict who will benefit from treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2013-09 |
| Est. Completion | 2019-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02225730
The ClinicalTrials.gov registry entry for NCT02225730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02225730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02225730 about?
NCT02225730 is a clinical study titled "Imaging Collaterals in Acute Stroke (iCAS)". Stroke is caused by a sudden blockage of a blood vessel that delivers blood to the brain. Unblocking the blood vessel with a blood clot removal device restores blood flow and if done quickly may prevent the disability that can be caused by a stroke. However, not all stroke patients benefit from hav...
What is the current status of trial NCT02225730?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2013-09. Estimated completion is 2019-10-31.
Who is sponsoring clinical trial NCT02225730?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.